Accolade, Inc. (ACCD): Multiplikator Forward P/S

Logo korporat perusahaan Accolade, Inc. (ACCD)

Accolade focuses on organic growth within the corporate B2B segment by developing IT integrations with insurance companies. Analyzing the chart on GURU.Markets, we note that the forward P/S trajectory has reached the 1.30 level, confirming market confidence in the model's scalability. This is supported by a strong corporate culture and commitment to personnel, as well as unique healthcare benefit navigation that saves costs for the largest US employers.

Accolade, Inc. - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ACCD (periode 04.07.2022 - 19.04.2025)

Ringkesan rincian data analitis accolade.com (ACCD)

- rega saiki lan proyeksi nilai saham:
Rega saham Accolade, Inc.|ACCD - Prakiraan konsensus analis
- data kapitalisasi bursa:
Kapitalisasi pasar ACCD|ACCD - Nilai Bisnis
- statistik nilai buku emiten:
Nilai Buku saben Saham Accolade|ACCD - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku accolade.com|ACCD - Total Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Accolade|ACCD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Accolade, Inc.|ACCD - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ACCD|ACCD - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Accolade|Rasio cepet accolade.com
- rincian asil keuangan lan kelipatan valuasi:
ACCD - Penghasilan resik perusahaan|Bathi sing dikarepake Accolade|ACCD - Rasio rega marang bathi|Pangali Forward P/E Accolade, Inc.|ACCD - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ACCD|ACCD - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Accolade|ACCD - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan accolade.com|ACCD - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Accolade
- rincian pendapatan lan dodolan:
ACCD - Pendapatan lan volume dodolan|Prakiraan volume dodolan Accolade, Inc.|ACCD - Kapitalisasi marang pendapatan|Multiplikator Forward P/S ACCD
Analisis kabeh metrik perusahaan:Accolade Health ACCD
Sampel barang accolade.com

The scalability of the Accolade (ACCD) cloud platform via AI-sorting and self-service directly impacts the forward P/S history, reflecting the market's valuation of future sales efficiency. This indicator is calculated as the ratio of current market capitalization to expected revenue, capturing investor reaction to the cost of capital; reaching historical highs signals that the asset is overbought and carries a high risk of correction.

Analisis pesaing Accolade

Multiplikator Forward P/S HIMS (Hims & Hers)|Multiplikator Forward P/S Hinge Health, Inc. HNGE|Teladoc Inc. - Multiplikator Forward P/S|TALK (Talkspace Platform) - Kapitalisasi marang prakiraan pendapatan|LFMD: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep amwell.com (AMWL)|MGRX (Mangoceuticals Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S DarioHealth Corp|Multiplikator Forward P/S VSEE|Multiplikator forward rega marang pendapatan Mobile-health Corp MNDR|Multiplikator Forward P/S BTCY (Biotricity, Inc.)|LYT - Multiplikator forward rega marang pendapatan|Ontrak - Multiplikator Forward P/S|SHLT (SHL Telemedicine Ltd.) - Kapitalisasi marang prakiraan pendapatan|THRN (Thorne) - Multiplikator forward rega marang pendapatan